NCT05233436 2026-02-19PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsPfizerPhase 1 Terminated21 enrolled
NCT05489250 2026-02-05PLATONInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestTerminated565 enrolled
NCT05070247 2026-01-22A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTakedaPhase 1/2 Terminated61 enrolled 29 charts
NCT04260802 2026-01-12A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersOcellaris Pharma, Inc.Phase 1/2 Terminated73 enrolled